TP53 and prostate cancer: In primary prostate cancer a relatively low incidence (10-20%) of p53 gene mutations has been described, however, in advanced stages of the disease the p53 is mutated in 42% of the cases (51-53) and it is associated with bone metastases and androgen-independent disease.